CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies

Clinical trial NCT06208735 · RECRUITING

Trial details

NCT number: NCT06208735
Sponsor: British Columbia Cancer Agency
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

B-Cell Leukemia Non-Hodgkin's Lymphoma B-cell Acute Lymphoblastic Leukemia Diffuse Large B Cell Lymphoma High-grade B-cell Lymphoma Primary Mediastinal Large B-cell Lymphoma (PMBCL)Mantle Cell Lymphoma B-cell Lymphoma

Start date: 2025-01-02
Primary completion: 2026-08-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.